| abstract |
The present invention relates to compounds of general formula (I), and stereoisomers, pharmaceutically acceptable salts, prodrugs, solvates, hydrates, and crystalline forms thereof. The compound of the general formula (I) can inhibit bromodomain recognition protein, and is used for regulating and controlling the apparent state of cells and treating a series of diseases and symptoms mediated by the bromodomain recognition protein, particularly treating hematological malignant tumors, midline cancers, inflammations and the like. |